Michèle Haumont

1.2k total citations
19 papers, 908 citations indexed

About

Michèle Haumont is a scholar working on Epidemiology, Animal Science and Zoology and Genetics. According to data from OpenAlex, Michèle Haumont has authored 19 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Animal Science and Zoology and 6 papers in Genetics. Recurrent topics in Michèle Haumont's work include Herpesvirus Infections and Treatments (11 papers), Animal Virus Infections Studies (6 papers) and Virus-based gene therapy research (5 papers). Michèle Haumont is often cited by papers focused on Herpesvirus Infections and Treatments (11 papers), Animal Virus Infections Studies (6 papers) and Virus-based gene therapy research (5 papers). Michèle Haumont collaborates with scholars based in Belgium, Netherlands and Canada. Michèle Haumont's co-authors include Alex Bollen, Alain Jacquet, Philippe Léonard, Martine Denis, Michel Moutschen, Françoise Smets, Étienne Sokal, Lida Garcia, Corinne Vandermeulen and André Moreels and has published in prestigious journals such as The Journal of Infectious Diseases, Infection and Immunity and Gene.

In The Last Decade

Michèle Haumont

19 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michèle Haumont Belgium 15 464 343 215 207 159 19 908
Nina Wedderburn United Kingdom 18 239 0.5× 276 0.8× 365 1.7× 131 0.6× 100 0.6× 55 931
G. Milanesi Italy 18 777 1.7× 315 0.9× 174 0.8× 99 0.5× 39 0.2× 44 1.3k
E M Walker United States 11 215 0.5× 219 0.6× 597 2.8× 220 1.1× 40 0.3× 18 1.3k
Zsolt Tóth United States 21 1.1k 2.3× 1.1k 3.3× 339 1.6× 80 0.4× 116 0.7× 41 1.7k
Sarah A. Connolly United States 16 1.4k 2.9× 259 0.8× 491 2.3× 98 0.5× 39 0.2× 31 1.6k
Mark Manak United States 16 252 0.5× 196 0.6× 82 0.4× 32 0.2× 53 0.3× 40 824
Yvon Sterkers France 25 823 1.8× 94 0.3× 173 0.8× 540 2.6× 42 0.3× 70 1.9k
David Jesse Sanchez United States 12 507 1.1× 411 1.2× 811 3.8× 40 0.2× 35 0.2× 21 1.4k
Vladimı́r Vonka Czechia 19 552 1.2× 247 0.7× 297 1.4× 22 0.1× 43 0.3× 58 920
Mandana Mansouri United States 10 424 0.9× 237 0.7× 428 2.0× 48 0.2× 28 0.2× 10 1.0k

Countries citing papers authored by Michèle Haumont

Since Specialization
Citations

This map shows the geographic impact of Michèle Haumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Haumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Haumont more than expected).

Fields of papers citing papers by Michèle Haumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Haumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Haumont. The network helps show where Michèle Haumont may publish in the future.

Co-authorship network of co-authors of Michèle Haumont

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Haumont. A scholar is included among the top collaborators of Michèle Haumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Haumont. Michèle Haumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Faber, Bart W., Edmond J. Remarque, Clemens H. M. Kocken, et al.. (2008). Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. Vaccine. 26(48). 6143–6150. 28 indexed citations
2.
3.
Moutschen, Michel, Philippe Léonard, Étienne Sokal, et al.. (2007). Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults. Vaccine. 25(24). 4697–4705. 121 indexed citations
4.
Jacquet, Alain, et al.. (2003). Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1. Clinical & Experimental Allergy. 33(2). 218–225. 20 indexed citations
5.
Jacquet, Alain, Michèle Haumont, Marc Massaer, et al.. (2002). Immunogenicity of a recombinant varicella-zoster virus gE–IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation. Vaccine. 20(11-12). 1593–1602. 14 indexed citations
6.
Massaer, Marc, et al.. (2001). High-Level Expression in Mammalian Cells of Recombinant House Dust Mite Allergen ProDer p 1 with Optimized Codon Usage. International Archives of Allergy and Immunology. 125(1). 32–43. 36 indexed citations
7.
Jacquet, Alain, et al.. (2001). The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans. Molecular and Biochemical Parasitology. 116(1). 35–44. 94 indexed citations
8.
Houard, Sophie, et al.. (2000). Cloning, expression and purification of recombinant cotton rat interleukin-5. Gene. 257(1). 149–155. 1 indexed citations
9.
Haumont, Michèle, Lida Garcia, Vincent Verlant, et al.. (2000). Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model. Infection and Immunity. 68(9). 4948–4953. 56 indexed citations
10.
Massaer, Marc, Michèle Haumont, Lida Garcia, et al.. (1999). Differential Neutralizing Antibody Responses to Varicella-Zoster Virus Glycoproteins B and E Following Naked DNA Immunization. Viral Immunology. 12(3). 227–236. 1 indexed citations
11.
Jacquet, Alain, et al.. (1999). Expression of a Recombinant Toxoplasma gondii ROP2 Fragment as a Fusion Protein in Bacteria Circumvents Insolubility and Proteolytic Degradation. Protein Expression and Purification. 17(3). 392–400. 37 indexed citations
12.
Houard, Sophie, et al.. (1999). Cloning, expression and purification of recombinant cotton rat interferon-gamma. Gene. 240(1). 107–113. 6 indexed citations
13.
Biemans, Ralph, D. Grégoire, Michèle Haumont, et al.. (1998). The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. Journal of Biotechnology. 66(2-3). 137–146. 43 indexed citations
14.
Jacquet, Alain, Michèle Haumont, Marc Massaer, et al.. (1998). The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans. Virus Research. 53(2). 197–207. 44 indexed citations
15.
Haumont, Michèle, H. O. Kangro, Alain Jacquet, et al.. (1997). Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization. Journal of Medical Virology. 53(1). 63–68. 17 indexed citations
16.
17.
Jacquet, Alain, Marc Massaer, Michèle Haumont, et al.. (1995). Purification and Characterization of Recombinant Varicella-Zoster Virus Glycoprotein gpII, Secreted by Chinese Hamster Ovary Cells. Protein Expression and Purification. 6(1). 91–98. 8 indexed citations
18.
Haeseleer, Françoise, et al.. (1993). Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria. Molecular and Biochemical Parasitology. 57(1). 117–126. 27 indexed citations
19.
Massaer, Marc, et al.. (1993). Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus. Journal of General Virology. 74(3). 491–494. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Wedderburn Breakdown of academic impact, for papers by G. Milanesi Breakdown of academic impact, for papers by E M Walker Breakdown of academic impact, for papers by Zsolt Tóth Breakdown of academic impact, for papers by Sarah A. Connolly Breakdown of academic impact, for papers by Mark Manak Breakdown of academic impact, for papers by Yvon Sterkers Breakdown of academic impact, for papers by David Jesse Sanchez Breakdown of academic impact, for papers by Vladimı́r Vonka Breakdown of academic impact, for papers by Mandana Mansouri
Rankless by CCL
2026